November/December 2022

Proceed with Caution

Allen C. Ho, MD, and Robert L. Avery, MD

ARDS 2022: The Panels

Experts discussed advances in AMD care, surgical innovation, breakthroughs in imaging, and more.

Rebecca Hepp, Editor-in-Chief

23rd Annual Advanced Vitreoretinal Techniques & Technology in Chicago

AVTT’s dynamic program was a big hit with everyone who attended this year. Get the recap here.

Alexis Warren, MD, and Daniel Wang, MD

Defining Ocular Ischemic Processes: An Atlas

Advanced imaging can improve the identification of ocular manifestations of systemic conditions.

Robert Sergott, MD

Managing a Giant Retinal Tear Without Vitrectomy

Laser retinopexy alone may be an option for select patients with macula-sparing GRTs.

Nhuong-Sao Ton, MS, and Murtaza Adam, MD

Pearls for Implanting a Carlevale IOL

A brief overview of the steps for a sutureless scleral-fixated IOL in the absence of capsular support.

Kai Januschowski, MD; Lukas Bisorca-Gassendorf, MD; Karl T. Boden, MD; and Annekatrin Rickmann, MD

What’s in the Works for Wet AMD

Researchers are pushing forward with novel therapeutics and delivery approaches.

Meghana Kalavar, MD; Dante Pieramici MD; and Nika Bagheri, MD

Recent Happenings in the Geographic Atrophy Space

Many new therapies are pushing their way through the pipeline.

Ruby Hollinger, BA; Viet Chau, MD; and Jayanth Sridhar, MD

DR Research Roundup: Phase 2 and 3

A look at new ways to use trusted treatments and novel pathways to fight diabetic eye disease.

Lauren Kiryakoza, MD, and Jayanth Sridhar, MD

Clinical Trials Targeting RVO

New therapeutics under investigation are showing promise for the treatment of retinal vein occlusion.

Jessica Lee, BS; Linnet Rodriguez, MD; Meera D. Sivalingam, MD; and Yoshihiro Yonekawa, MD

Retinal Imaging Pipeline Updates

New tools are providing researchers ways to see the retina like never before.

Kara Rickford, MS, and Jay Chhablani, MD

The Path to Product Launch

Experts share their four-step approach to product development and commercialization.

Steve Charles, MD, FACS, FICS, and Adam Pflugrath, MD

Intraarterial Chemotherapy for Recurrent Retinoblastoma

An excellent option for primary and secondary therapy.

Rachel S. Kim, BS; Kushal U. Agrawal, MS; and Carol L. Shields, MD

Mizuo-Nakamura Phenomenon in X-linked Retinoschisis

This finding may be present in cases of XLRS in the absence of genetic variants for Oguchi disease.

Natasha Ferreira Santos da Cruz, MD; Ashley Lopez-Canizares, MS; and Audina M. Berrocal, MD

A Toxic Side Effect of Dropless Surgery

Be careful of potentially toxic compounds found in some triamcinolone-moxifloxacin injections used in cataract surgery in place of postoperative drops.

Kishan G. Patel, MD, and Ashkan M. Abbey, MD

5Q with Jonathan F. Russell, MD, PhD

Jonathan F. Russell, MD, PhD